← Evidence map

ReviewPharmacoEconomics2012

Bevacizumab for metastatic colorectal cancer: a NICE single technology appraisal.

Sophie Whyte et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

25 papers cite it

2012
2013
2014
2015
2016
2017
2018
2019
2020
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 23058097